Oncolytics Biotech Inc ONCY

Antibody-Drug Conjugate (ADC) developments

[Noteable]

https://stockhouse.com/companies/bullboard?symbol=t.onc&threadid=35525030

[Noteable]

August 22, 2024 - Health Canada has granted approval of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with enfortumab vedotin, an antibody-drug conjugate, for the treatment of adult patients with unresectable locally advanced or metastatic urothelial cancer (mUC) [bladder cancer] with no prior systemic therapy for mUC [bladder cancer].  https://www

[Noteable]

September 23, 2023 - AstraZeneca, Daiichi’s Enhertu successor faces more questions after latest stumble The partners said their antibody-drug conjugate datopotomab deruxtecan didn’t extend survival in a breast cancer study, fueling doubts about its approval prospects.    But the future of datopotomab deruxtecan, or dato-dxd for short, is now unclear. In lung cancer, it similarly

[Noteable]

November 08, 2024 - Over the first half of this year, Daichi Sanyo/Astrazeneca's ADC Enhertus sales stalled out with $893 million in combined sales collected over the second quarter, marking a sequential increase of only 1.6%. AstraZeneca blamed the slowdown partly on a destocking dynamic in China following an inventory buildup in the first quarter. Meanwhile in England, the country’s

[Noteable]

AstraZeneca’s stock price drops after a report fueled fears of a potentially escalating insurance fraud investigation in China.  AZ said it believes Chinese authorities are looking into whether the company's employees had illegally imported the HER2-targeted antibody-drug conjugate Enhertu.  https://www.fiercepharma.com/pharma/astrazeneca-stock-tanks-over-fears-expanding-china

[Noteable]

Following reports of an ex-AstraZeneca executive being detained in China, the company acknowledged that its current president in the country, Leon Wang, "is cooperating with an ongoing investigation." The development surrounding Wang comes quickly on the heels of a report that BeiGene executive Eva Yin had been detained by anti-smuggling authorities in Shenzhen. Before joining BeiGene

[Noteable]

China's investigation has resulted in a series of charges against AZ staffers and convictions with prison sentences of more than 10 years in some cases, according to local media reports. Another line of enquiry, which first emerged earlier this year, involves data privacy breaches and the import of unlicensed medicines. Now, it has been reported by analysts that the illegal imports